As of January 2026 GenSight Biologics has a market cap of ยฃ17.75 Million. This makes GenSight Biologics the world's 10106th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.